Editorial Commentary
The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial
Translational Cancer Research
2025;
14
(3)
:1507-1510
.
(30 March 2025)
Circulating tumor cell-based PSMA and PSA expression as a predictive and prognostic tool in prostate cancer
Translational Cancer Research
2025;
14
(3)
:1511-1515
.
(30 March 2025)
Original Article
Development and validation of a prediction model based on two-dimensional dose distribution maps fused with computed tomography images for noninvasive prediction of radiochemotherapy resistance in non-small cell lung cancer
Translational Cancer Research
2025;
14
(3)
:1516-1530
.
(30 March 2025)
Targeting PAR-2-driven inflammatory pathways in colorectal cancer: mechanistic insights from atorvastatin and rosuvastatin treatment in cell line models
Translational Cancer Research
2025;
14
(3)
:1531-1566
.
(30 March 2025)
Oncologic and obstetric outcomes of a novel nerve-sparing radical trachelectomy while preserving the uterine branches of the pelvic nerves
Translational Cancer Research
2025;
14
(3)
:1567-1575
.
(30 March 2025)
Risk factors, prognostic factors and nomograms for distant metastasis in colorectal neuroendocrine neoplasms: a SEER-based study
Translational Cancer Research
2025;
14
(3)
:1576-1595
.
(30 March 2025)
Prediction of visceral pleural invasion of clinical stage IA lung adenocarcinoma based on computed tomography features
Translational Cancer Research
2025;
14
(3)
:1596-1608
.
(30 March 2025)
Incidence, clinical features, and survival outcomes of primary malignant conjunctival tumor: a US population-based retrospective cohort analysis based on the SEER database (1975–2018)
Translational Cancer Research
2025;
14
(3)
:1609-1625
.
(30 March 2025)
Small peritoneal macrophages are accelerators of peritoneal metastasis of colorectal cancer
Translational Cancer Research
2025;
14
(3)
:1626-1637
.
(30 March 2025)
Scoparone suppresses proliferation and cell cycle of hepatocellular carcinoma cells via inhibiting AKT/GSK-3β/cyclin D1 signaling pathway
Translational Cancer Research
2025;
14
(3)
:1638-1650
.
(30 March 2025)
Development and validation of nomograms for predicting the prognosis of colorectal cancer patients
Translational Cancer Research
2025;
14
(3)
:1651-1663
.
(30 March 2025)
Triage of women with positive HPV: comparing DNA ploidy analysis with HPV 16/18 genotyping and cervical cytology
Translational Cancer Research
2025;
14
(3)
:1664-1674
.
(30 March 2025)
Comprehensive analysis of molecular characteristics between primary and breast-derived metastatic ovarian cancer
Translational Cancer Research
2025;
14
(3)
:1675-1690
.
(30 March 2025)
Comparative survival analysis of stage T1-T2N0M0 lung squamous cell carcinoma and adenocarcinoma using SEER data, and nomogram analysis for early-stage lung squamous cell carcinoma
Translational Cancer Research
2025;
14
(3)
:1691-1709
.
(30 March 2025)
Individualized estimation of conditional survival for patients with spinal chordoma
Translational Cancer Research
2025;
14
(3)
:1710-1724
.
(30 March 2025)
Revisiting lymph node guidelines: limited lymph node examination might be sufficient for elderly gastric cancer patients
Translational Cancer Research
2025;
14
(3)
:1725-1736
.
(30 March 2025)
Identification of novel neutrophil-extracellular-traps-related genes as biomarkers for breast cancer prognosis and immunotherapy
Translational Cancer Research
2025;
14
(3)
:1737-1752
.
(30 March 2025)
Predicting bone marrow suppression from urinal 8-hydroxy-2'-deoxyguanosine level during the treatment with radium-223 in patients with cancer bone metastasis
Translational Cancer Research
2025;
14
(3)
:1753-1763
.
(30 March 2025)
Association between diffusion-weighted imaging and tumor matrix in liver cancer: a cross-sectional study
Translational Cancer Research
2025;
14
(3)
:1764-1771
.
(30 March 2025)
Molecular subtype and prognostic model of laryngeal squamous cell carcinoma based on neutrophil extracellular trap-related genes
Translational Cancer Research
2025;
14
(3)
:1772-1785
.
(30 March 2025)
KRT14 knockdown reduces cisplatin resistance by lowering LRP11 expression levels in cisplatin-resistant ovarian cancer cell lines
Translational Cancer Research
2025;
14
(3)
:1786-1798
.
(30 March 2025)
Integrated machine learning constructed a circadian-rhythm-related model to assess clinical outcomes and therapeutic advantages in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(3)
:1799-1823
.
(30 March 2025)
Estrogen receptor β inhibits breast cancer migration and promotes its apoptosis through NF-κB/IL-8 signaling
Translational Cancer Research
2025;
14
(3)
:1824-1835
.
(30 March 2025)
Radiomics-clinical nomogram for preoperative tumor-node-metastasis staging prediction in breast cancer patients using dynamic enhanced magnetic resonance imaging
Translational Cancer Research
2025;
14
(3)
:1836-1848
.
(30 March 2025)
Causal associations between atrial fibrillation and esophageal cancer: a two-sample Mendelian randomization study
Translational Cancer Research
2025;
14
(3)
:1849-1856
.
(30 March 2025)
Analysis and assessment of ferroptosis-related gene signatures and prognostic risk models in skin cutaneous melanoma
Translational Cancer Research
2025;
14
(3)
:1857-1873
.
(30 March 2025)
Feasibility and patient reported tolerance of cryotherapy with Cooral mouth cooling device in patients undergoing radiation therapy (CooRay): a pilot study
Translational Cancer Research
2025;
14
(3)
:1874-1883
.
(30 March 2025)
Prediction of the prognosis of intrahepatic cholangiocarcinoma patients after hepatectomy via propensity score matching: a competitive risk model analysis
Translational Cancer Research
2025;
14
(3)
:1884-1901
.
(30 March 2025)
Enhanced prognostic prediction of cancer-specific mortality in elderly bladder cancer patients post-radical cystectomy: an XGBoost model study
Translational Cancer Research
2025;
14
(3)
:1902-1914
.
(30 March 2025)
A novel mesenchymal epithelial transition (MET) inhibitor, CB538, relieves acquired resistance in EGFR-mutated MET-amplified non-small cell lung cancer
Translational Cancer Research
2025;
14
(3)
:1915-1927
.
(30 March 2025)
Survival analysis of gastric malignancy patients: identifying key prognostic factors
Translational Cancer Research
2025;
14
(3)
:1928-1941
.
(30 March 2025)
Induction of ferroptosis in oxaliplatin-resistant colorectal cancer cells by extract from Actinidia chinensis Planch radix
Translational Cancer Research
2025;
14
(3)
:1942-1951
.
(30 March 2025)
Impact of Shenling Baizhu Powder on lipid profiles and body mass index in breast cancer patients under adjuvant chemotherapy: a retrospective study
Translational Cancer Research
2025;
14
(3)
:1952-1970
.
(30 March 2025)
The identification and prediction of lung adenocarcinoma prognosis using a novel gene signature associated with DNA replication
Translational Cancer Research
2025;
14
(3)
:1971-1981
.
(30 March 2025)
Causal relationship between gut microbiota and malignant lymphoma: a two-way two-sample mendelian randomization study
Translational Cancer Research
2025;
14
(3)
:1982-1994
.
(30 March 2025)
Biological and clinical significance of circulating mucosal-associated invariant T cells in lung cancer
Translational Cancer Research
2025;
14
(3)
:1995-2009
.
(30 March 2025)
Development of coenzyme Q10-related molecular subtypes and a prognostic signature for predicting breast cancer prognosis and response to immunotherapy
Translational Cancer Research
2025;
14
(3)
:2010-2028
.
(30 March 2025)
Research on the error pattern recognition of dosimetric quality assurance by Bayesian optimization
Translational Cancer Research
2025;
14
(3)
:2029-2042
.
(30 March 2025)
Retrospective study on the prognostic prediction of inflammatory markers and the C-reactive protein/albumin ratio in first-line immunotherapy for advanced HER2 negative gastric cancer patients
Translational Cancer Research
2025;
14
(3)
:2043-2053
.
(30 March 2025)
A gene signature associated with cellular senescence serves as an important prognostic indicator in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(3)
:2054-2065
.
(30 March 2025)
Diagnostic test of conventional ultrasonography combined with contrast-enhanced ultrasound in the subcategorization of suspicious Breast Imaging-Reporting and Data System (BI-RADS) 4 breast lesions
Translational Cancer Research
2025;
14
(3)
:2066-2077
.
(30 March 2025)
Arsenic enhances cervical cancer cell radiosensitivity by suppressing the DNA damage repair pathway
Translational Cancer Research
2025;
14
(3)
:2078-2094
.
(30 March 2025)
Investigation of mitochondrial DNA methylation-related prognostic biomarkers in hepatocellular carcinoma using The Cancer Genome Atlas (TCGA) database
Translational Cancer Research
2025;
14
(3)
:2095-2112
.
(30 March 2025)
Construction of a postoperative liver metastasis prediction model for colorectal cancer based on spectral CT imaging, CEA, and CA19-9
Translational Cancer Research
2025;
14
(3)
:2113-2124
.
(30 March 2025)
Review Article
A narrative review of papillary thyroid carcinoma-related long non-coding RNAs and their relevance to malignant tumors
Translational Cancer Research
2025;
14
(3)
:2125-2149
.
(30 March 2025)
Current advances in the functional role of long non-coding RNAs in the oncogenesis and metastasis of esophageal squamous cell carcinoma: a narrative review
Translational Cancer Research
2025;
14
(3)
:2150-2167
.
(30 March 2025)
Letter to the Editor
Central nervous system and osteodural multiple myeloma
Translational Cancer Research
2025;
14
(3)
:2168-2169
.
(30 March 2025)
